Skip to Main Content

Publications Co-authored or Contributed to by Library Staff

Editing Services

Our Editing Services team currently employs 13 editors (including editorial managers), many with more than 25 years of editing experience. The editors perform both substantive editing and copy-editing of grant proposals, journal articles, and other materials. 

Literature Search Services

The Research Services team offers expertise on literature searching, systematic reviews and author and publication metrics to MD Anderson Cancer Center employees. We have years of combined searching experience using a variety of resources including MEDLINE, EMBASE, CINAHL, Web of Science, and many more.

Legend

Symbol Definition
Editing Publications that have been edited.
Searching Publications that have had searching assistance.
Co-Authorship Publications with library co-authors.
Star Publications with two or more types of contributions.

Publications Co-authored or Contributed to by Library Staff

In fiscal year 2022-2023, Research Medical Library staff have co-authored or been acknowledged for their contributions to the following publications. Names of library co-authors are in bold; for publications without a library co-author, the specific library contribution (e.g., Literature Searching; Editing) is noted. 

2023 RML Contributed Publications

RML publications by years

July 2024

Contribution Citation Altmetric Badge
Editing

Tino R, Roach MA, Fuentes GD, et al. Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy. Oral Oncol. 2024 Jul 17:157:106944.
 
Editing

Raghavendra AS, Jennings K, Guerra G, Tripathy D, Karuturi MS. Patient-reported convenience and effectiveness of telehealth for breast cancer management. Oncologist. 2024 Jul 17.
 
Editing

Snyder RA, Zemla TJ, Shi Q, et al. Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501). Ann Surg Oncol. 2024 Jul 15.
 
Editing

Mohamed RM, Panthi B, Adrada BE, et al. Multiparametric MRI–based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Sci Rep. 2024 Jul 12;14(1):16073.
 
Editing

Shah J, Devalaraju S, Baerman E, et al. Gastrointestinal toxicities of proteasome inhibitor therapy. J Cancer Res Clin Oncol. 2024 Jul 5;150(7):334.
 
Editing

Aslan B, Manyam G, Iles LR, et al. Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib. Blood Adv. 2024 Jul 5.
 
Editing

Wang XS, Shi Q, Shen S-E, et al. Patient-reported outcomes after oncologic hepatic resection predict the risk of delayed readiness to return to intended oncologic therapy (RIOT). Eur J Surg Oncol. 2024 Jul;50(7):108396.
 
Editing

Villalba AJA, Ost DE. Bronchoscopic treatment of early-stage peripheral lung cancer. Curr Opin Pulm Med. 2024 Jul 1;30(4):337-345.
 

June 2024

Contribution Citation Altmetric Badge
Searching

Sheen S, Zemmedhun G, Roldan CJ. Opioids for oral mucositis-related pain: a narrative review. JOMA. 2024 Jun 30.
 
Editing

Khavandi MM, Habibollahi P. Trans-splenic Sharp Recanalization, Extra-Anatomic Portal Vein Reconstruction, and Intrahepatic Portosystemic Shunt creation for the Treatment of Portal Hypertension in a Patient with Polycythemia Vera and JAK2 Mutation. Cardiovasc Intervent Radiol. 2024 Jun 27.
 
Editing

Chen F, Nagarajan P, Aung PP. Digital Papillary Adenocarcinoma: The Detection of Low-Risk Human Papillomaviruses and the BRAF p.V600E Mutation in a Subset of Cases. Dermatopathology 2024, 11(3), 177-183. 2024 Jun 28.
 
Editing

Elmorsi R, Camacho L, Krijgh DD, et al. Optimizing Morbidity in Unplanned Soft Tissue Sarcoma Excisions: Should We Skip the Reconstructive Ladder?. Ann Plast Surg. 2024 Jun 24.
 
Editing

Agusti N, Viveros-Carreño D, Melamed A, et al. Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer. Int J Gynecol Cancer. 2024 Jun 25:ijgc-2024-005570.
 
Editing

Barcena AJR, Perez JVD, Bernardino MR, et al. Controlled Delivery of Rosuvastatin or Rapamycin through Electrospun Bismuth Nanoparticle-Infused Perivascular Wraps Promotes Arteriovenous Fistula Maturation. ACS Appl Mater Interfaces. 2024 Jun 24.
 
Editing

Raghavendra AS, Liu D, Shen Y, et al. Outcomes of older adults with early-stage triple-negative breast cancer (TNBC) receiving chemotherapy: a single-institution experience. Breast Cancer Res Treat. 2024 Jun 25.
 
Co-Author

Alqahtani S, Gibbs KD, Montanez NA, Krause KJ, van Ommen CH, Srivaths LV. Direct oral anticoagulant therapy in adolescent venous thromboembolism: A systematic review. Pediatr Blood Cancer. 2024 Jun 20:e31131.
 
Editing

Devarajan E, Davis RE, Beird HC, et al. Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases. Discov Oncol. 2024 Jun 18;15(1):232.
 
Editing

Yu Y, Cao W-M, Cheng F, et al. FOXK2 amplification promotes breast cancer development and chemoresistance. Cancer Lett. 2024 Jun 18:217074.
 
Editing

Chahla B, Pal K, Balderrama-Brondani V, et al. Clinical outcomes of image-guided therapies in patients with adrenocortical carcinoma: a tertiary referral center retrospective study. Oncologist. 2024 Jun 13:oyae130.
 
Editing

Perez A, Baumann DP, Viola GM. Reconstructive breast implant-related infections: Prevention, diagnosis, treatment, and pearls of wisdom. J Infect. 2024 Jun 13;89(2):106197.
 
Editing

Ali MA, Aiman W, Kantarjian H, et al. Efficacy of Chemotherapy-Free Regimens in the Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia. 2024 Jun 12.
 
Editing

Kim M, Maldonado JA, Pandey P, et al. Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic. BMJ Support Palliat Care. 2024 Jun 6:spcare-2023-004497.
 
Editing

Nead KT, Kim T, Joo L, et al. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Blood Adv. 2024 Jun 3.
 
Editing

Lim B, Seth S, Yam C, et al. Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into “ARness”. Cell Rep Med. 2024 Jun 18;5(6):101595.
 
Editing

Toale KM, Butler G, Richardson G, Beno J, Jawe N. Improving Compliance with a Nurse-Driven Protocol for Unfractionated Heparin Infusions in Patients with Venous Thromboembolism. Am J Nurs. 2024 Jun 1;124(6):40-46.
 
Editing

Montalban-Bravo G, Thongon N, Rodriguez-Sevilla JJ, et al. Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia. Cell Rep Med. 2024 Jun 18;5(6):101585.
 
Editing

Wilke RN, Bednar EM, Pirzadeh-Miller S, et al. Cascade genetic testing: an underutilized pathway to equitable cancer care?. Fam Cancer. 2024 Jun;23(2):141-145.
 
Subjects: Data Visualization